Literature DB >> 6149468

Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine.

G Laschinski, B Kittner, M Bräutigam.   

Abstract

The inhibitory effect of apomorphine on tyrosine hydroxylase (TH) was tested using enzyme preparations from rat striatum, neuroblastoma clone N1E-115 and pheochromocytoma clone PC-12. When the striatal enzyme preparation was incubated at pH 7.2 with (6R,S)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4) as cofactor (100-1,000 mumol/l), the IC50 for apomorphine was found to be in the 0.1-1 mumol/l range depending on the BH4-concentration used. Changing the incubation medium to pH 6.0 yielded an IC50 of about 2.5 mumol/l (BH4 = 100 mumol/l). Apomorphine was even less effective when 2-amino-4-hydroxy-6,7-dimethyl-5,6,7,8-tetrahydropteridine (100 mumol/l) was used as cofactor (IC50 approximately 10 mumol/l). Similar results were obtained with the enzyme preparations of the two cell clones. These experiments show that, even in low concentrations, apomorphine inhibits TH directly, provided more physiological test conditions are used. The relevance of these results for the autoreceptor-mediated mechanism of the apomorphine action on catecholamine synthesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149468     DOI: 10.1007/bf00500904

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  32 in total

1.  Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.

Authors:  L L Iversen; M A Rogawski; R J Miller
Journal:  Mol Pharmacol       Date:  1976-03       Impact factor: 4.436

2.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

3.  Lergotrile and lisuride: in vivo dopaminergic agonists which do not stimulate the presynaptic dopamine autoreceptor.

Authors:  J W Kebabian; P R Kebabian
Journal:  Life Sci       Date:  1978-11-27       Impact factor: 5.037

4.  Presynaptic regulation of tyrosine hydroxylase activity in rat striatal synaptosomes by dopamine analogs.

Authors:  W G Waggoner; J McDermed; H J Leighton
Journal:  Mol Pharmacol       Date:  1980-07       Impact factor: 4.436

5.  Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line.

Authors:  K A Markey; H Kondo; L Shenkman; M Goldstein
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

6.  Separation and properties of the 6-diastereoisomers of l-erythro-tetrahydrobiopterin and their reactivities with phenylalanine hydroxylase.

Authors:  S W Bailey; J E Ayling
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

7.  On the mechanism of presynaptic autoreceptor-mediated inhibition of transmitter synthesis in dopaminergic nerve terminals.

Authors:  M Bitran; G Bustos
Journal:  Biochem Pharmacol       Date:  1982-09-15       Impact factor: 5.858

8.  Mouse neuroblastoma clone N1E-115: a suitable model for studying the action of dopamine agonists of tyrosine hydroxylase activity.

Authors:  M Bräutigam; R Dreesen; C W Flosbach; H Herken
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

9.  Effect of cyclic AMP-dependent protein phosphorylating conditions on the pH-dependent activity of tyrosine hydroxylase from beef and rat striata.

Authors:  R J Pollock; G Kapatos; S Kaufman
Journal:  J Neurochem       Date:  1981-10       Impact factor: 5.372

10.  Regional and subcellular distribution and some factors in the regulation of reduced pterins in rat brain.

Authors:  W P Bullard; P B Guthrie; P V Russo; A J Mandell
Journal:  J Pharmacol Exp Ther       Date:  1978-07       Impact factor: 4.030

View more
  7 in total

1.  Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.

Authors:  Lydia M Mexas; Virginia R Florang; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2011-04-14       Impact factor: 4.294

2.  Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.

Authors:  O Magnusson; C J Fowler; B Mohringe; A Wijkström; S O Ogren
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

3.  The effect of the dopamine agonist pergolide on tyrosine hydroxylase activity in rat striatal and limbic miniprisms in vitro: a model for the dopamine autoreceptor?

Authors:  A G Vulto; C J Fowler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

4.  Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?

Authors:  C J Fowler; G Thorell; M Andersson; O Magnusson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

5.  Inhibition of tyrosine hydroxylase in rabbit mesenteric artery and vas deferens by catechol oestrogens.

Authors:  D U Panek; A J Azzaro; R E Stitzel; R J Head
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

6.  Lack of autoreceptor mediated regulation of the spontaneous dopamine turnover in the isolated neurointermediate lobe of the rat pituitary gland in vitro.

Authors:  K Racké; B Hering; K Ziegler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

7.  Direct inhibition of tyrosine hydroxylase from PC-12 cells by catechol derivatives.

Authors:  G Laschinski; B Kittner; M Bräutigam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.